CJC-1295 vs Sermorelin: which GHRH analog actually wins

Once you decide you want a GH secretagogue, the first real choice usually comes down to two candidates: CJC-1295 and Sermorelin. They sound interchangeable in vendor copy — both are GHRH analogs, both stimulate endogenous GH release, both are dosed subcutaneously. They are not interchangeable. They have different half-lives, different dosing logic, different side-effect profiles, and they fit different goals.

This post is the comparison most users actually need before they commit to a stack. The short answer: Sermorelin is the cleaner, more conservative choice; CJC-1295 (especially the DAC version) is the more aggressive, longer-acting choice; and the right pick depends on what you're optimizing for and how much variability you're willing to tolerate.

What each molecule actually is

Sermorelin is the first 29 amino acids of natural human growth hormone-releasing hormone (GHRH 1-29). Native GHRH is 44 amino acids, but the receptor-binding activity is concentrated in the first 29 residues. Sermorelin reproduces that biological activity in a shorter, easier-to-manufacture form. Its half-life is short — roughly 10–20 minutes in circulation — which mimics the pulsatile pattern of natural GHRH release.

CJC-1295 is a modified GHRH 1-29 with substitutions designed to extend its half-life. There are two distinct forms:

• CJC-1295 with DAC (Drug Affinity Complex): includes a maleimidopropionic acid (MPA) modification that allows it to bind covalently to albumin in the bloodstream. This dramatically extends the half-life to roughly 6–8 days.
• CJC-1295 without DAC (also called Mod GRF 1-29): the same modified GHRH 1-29 without the albumin-binding component. Half-life is ~30 minutes — longer than Sermorelin but still effectively pulsatile.

The distinction between DAC and no-DAC versions is the most important factor in this comparison and is often glossed over in vendor materials. For deeper context see CJC-1295 DAC vs no-DAC.

Side-by-side comparison

Why half-life actually matters

This is the part most users underweight. GH release in healthy young adults is pulsatile — the pituitary releases GH in bursts, primarily during sleep and after exercise, with low baseline levels between pulses. This pulsatile pattern is biologically important. It allows GH receptors to reset between pulses, maintains feedback sensitivity, and prevents downregulation.

Sermorelin and CJC-1295 no-DAC produce GH pulses that look like natural pulses — short, sharp, and gone within an hour or two. The pituitary's secretory machinery and the downstream IGF-1 production work in their normal pattern. This is why these are sometimes called "physiologic" GH secretagogues.

CJC-1295 with DAC produces a sustained elevation of GH and IGF-1 that looks much less like natural release and more like continuous infusion. This produces stronger anabolic and lipolytic effects, but at the cost of moving further from the physiologic pattern, with more potential for downregulation, more water retention, and more sustained elevation of biomarkers.

For practical users, this translates to:

• Sermorelin and no-DAC CJC-1295 — closer to "natural amplification" of your own GH pattern
• DAC CJC-1295 — more like a partial GH replacement therapy in effect

Pick the model that matches your goals.

For broader context see GH stack: Ipamorelin and CJC-1295 and best injection timing.

Goal-fit decision matrix

For the broader stacking question see building your first peptide protocol and GH peptides in your 30s.

Side-effect profile differences

The side-effect profiles track the half-life logic.

Sermorelin (most physiologic) tends to produce:

• Mild injection-site reactions
• Occasional flushing immediately post-injection
• Vivid dreams or sleep changes (often welcomed)
• Minimal water retention
• Modest IGF-1 elevation, usually within normal range

CJC-1295 no-DAC is similar to Sermorelin with slightly more pronounced effects in each category.

CJC-1295 with DAC has a meaningfully different profile:

• More pronounced water retention (especially first 2–3 weeks)
• Joint aches more common (see joints ache on a GH cycle)
• Sustained IGF-1 elevation, sometimes outside normal range at higher doses
• Numbness/tingling (carpal tunnel-like) more reported
• Insulin sensitivity drift over longer cycles

For the broader side-effect frame see GH secretagogue side effects.

Sourcing considerations

A few practical notes:

• Sermorelin is one of the more commonly compounded GH peptides at 503A pharmacies, where prescription-route sourcing is straightforward
• CJC-1295 (especially no-DAC) is widely available research-chemical; the DAC version is less commonly compounded
• Verify which CJC-1295 you're buying. Many vendors label simply "CJC-1295" without specifying DAC vs no-DAC. The molecular weight and price are different — DAC versions cost more and have different storage requirements
• Storage: all three are stable lyophilized; once reconstituted, refrigerate and use within 30 days

For compounding vs research-chemical considerations see compounding pharmacy vs research-chemical peptides and vendor due diligence checklist.

The honest framing

If someone forced a one-word answer to "Sermorelin or CJC-1295?":

• For most first-time users and conservative protocols: Sermorelin
• For experienced users wanting more pulse amplitude in a stack: CJC-1295 no-DAC + Ipamorelin
• For users prioritizing convenience and accepting the tradeoffs: CJC-1295 with DAC + Ipamorelin

The wrong frame is "which is stronger" — they're different drugs with different mechanisms of action despite both being GHRH analogs. The right frame is matching the half-life and dosing pattern to what you're actually trying to achieve. Sermorelin's "weakness" is often the feature: it doesn't push too far past your natural rhythm.

Avoid the common mistake of starting with DAC CJC-1295 because it dosed less often. Convenience is real, but the sustained elevation pattern is less forgiving than the pulsatile alternatives if anything goes sideways with your response.

Related reading

• Choosing Sermorelin, Ipamorelin, or Tesamorelin
• CJC-1295 DAC vs no-DAC
• Sermorelin protocol
• GH stack: Ipamorelin and CJC-1295
• CJC-1295 long-term data conundrum